drugset

drugset / Trial / NCT00141414

To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.

NCT00141414 ↗

Phase 2 Completed 82 enrolled Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To evaluate the long-term safety of pregabalin in refractory partial epilepsy.

Timeline

Start: 1997-11
Primary completion: —
Completion: 2005-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pregabalin	Small molecule	—	—

Indications